Note 16 - Segment Financial Information (Details) - USD ($) |
12 Months Ended | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2015 |
Dec. 31, 2014 |
||||||||||||||||
Treatment [Member] | |||||||||||||||||
Revenue, Net | $ 41,318,000 | $ 42,343,000 | |||||||||||||||
Intercompany revenues | 113,000 | 12,000 | |||||||||||||||
Gross profit | 10,910,000 | 10,480,000 | |||||||||||||||
Research and Development Expense | 179,000 | $ 437,000 | |||||||||||||||
Interest income | 6,000 | ||||||||||||||||
Interest expense | (38,000) | $ (38,000) | |||||||||||||||
Interest expense-financing fees | (2,000) | ||||||||||||||||
Depreciation and amortization | 2,949,000 | $ 3,281,000 | |||||||||||||||
Segment income (loss) before income taxes | 7,101,000 | 6,149,000 | |||||||||||||||
Total income tax expense | 538,000 | 604,000 | |||||||||||||||
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest | 6,563,000 | 5,545,000 | |||||||||||||||
Segment assets | [1] | 46,307,000 | 50,226,000 | ||||||||||||||
Expenditures for segment assets | 579,000 | 399,000 | |||||||||||||||
Total debt | 23,000 | 47,000 | |||||||||||||||
Services [Member] | |||||||||||||||||
Revenue, Net | 21,065,000 | 14,722,000 | |||||||||||||||
Intercompany revenues | 25,000 | 70,000 | |||||||||||||||
Gross profit | $ 3,441,000 | 1,428,000 | |||||||||||||||
Research and Development Expense | $ 99,000 | ||||||||||||||||
Interest income | |||||||||||||||||
Interest expense | $ (1,000) | ||||||||||||||||
Interest expense-financing fees | 2,000 | ||||||||||||||||
Depreciation and amortization | $ 725,000 | 910,000 | |||||||||||||||
Segment income (loss) before income taxes | $ 1,178,000 | (2,184,000) | [2] | ||||||||||||||
Total income tax expense | (191,000) | ||||||||||||||||
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest | $ 1,178,000 | (1,993,000) | [2] | ||||||||||||||
Segment assets | [1] | 9,481,000 | 8,920,000 | ||||||||||||||
Expenditures for segment assets | $ 33,000 | $ 64,000 | |||||||||||||||
Total debt | |||||||||||||||||
Medical [Member] | |||||||||||||||||
Revenue, Net | |||||||||||||||||
Intercompany revenues | |||||||||||||||||
Gross profit | |||||||||||||||||
Research and Development Expense | $ 2,114,000 | $ 759,000 | |||||||||||||||
Interest income | |||||||||||||||||
Interest expense | |||||||||||||||||
Interest expense-financing fees | |||||||||||||||||
Depreciation and amortization | |||||||||||||||||
Segment income (loss) before income taxes | $ (2,114,000) | $ (759,000) | |||||||||||||||
Total income tax expense | |||||||||||||||||
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest | $ (2,114,000) | $ (759,000) | |||||||||||||||
Segment assets | [1] | $ 1,793,000 | $ 1,213,000 | ||||||||||||||
Expenditures for segment assets | |||||||||||||||||
Total debt | |||||||||||||||||
Segments Total [Member] | |||||||||||||||||
Revenue, Net | [3] | $ 62,383,000 | $ 57,065,000 | ||||||||||||||
Intercompany revenues | [3] | 138,000 | 82,000 | ||||||||||||||
Gross profit | [3] | 14,351,000 | 11,908,000 | ||||||||||||||
Research and Development Expense | [3] | 2,293,000 | $ 1,295,000 | ||||||||||||||
Interest income | 6,000 | [3] | |||||||||||||||
Interest expense | [3] | (38,000) | $ (39,000) | ||||||||||||||
Interest expense-financing fees | [3] | (2,000) | 2,000 | ||||||||||||||
Depreciation and amortization | [3] | 3,674,000 | 4,191,000 | ||||||||||||||
Segment income (loss) before income taxes | [3] | 6,165,000 | 3,206,000 | ||||||||||||||
Total income tax expense | [3] | 538,000 | 413,000 | ||||||||||||||
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest | [3] | 5,627,000 | 2,793,000 | ||||||||||||||
Segment assets | [1],[3] | 57,581,000 | 60,359,000 | ||||||||||||||
Expenditures for segment assets | [3] | 612,000 | 463,000 | ||||||||||||||
Total debt | [3] | $ 23,000 | $ 47,000 | ||||||||||||||
Corporate Segment [Member] | |||||||||||||||||
Revenue, Net | |||||||||||||||||
Intercompany revenues | |||||||||||||||||
Gross profit | |||||||||||||||||
Research and Development Expense | [4] | $ 9,000 | $ 20,000 | ||||||||||||||
Interest income | [4] | 47,000 | 27,000 | ||||||||||||||
Interest expense | [4] | (451,000) | (577,000) | ||||||||||||||
Interest expense-financing fees | [4] | (226,000) | (194,000) | ||||||||||||||
Depreciation and amortization | [4] | 43,000 | 49,000 | ||||||||||||||
Segment income (loss) before income taxes | [4] | (5,685,000) | (5,781,000) | ||||||||||||||
Total income tax expense | [4] | 5,000 | 4,000 | ||||||||||||||
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest | [4] | (5,690,000) | (5,785,000) | ||||||||||||||
Segment assets | [1],[5] | 25,484,000 | [4] | 27,892,000 | |||||||||||||
Expenditures for segment assets | [4] | 11,000 | 1,000 | ||||||||||||||
Total debt | [4],[6] | 9,965,000 | 11,325,000 | ||||||||||||||
Revenue, Net | $ 62,383,000 | $ 57,065,000 | |||||||||||||||
Intercompany revenues | |||||||||||||||||
Gross profit | $ 14,351,000 | $ 11,908,000 | |||||||||||||||
Research and Development Expense | 2,302,000 | 1,315,000 | |||||||||||||||
Interest income | 53,000 | 27,000 | |||||||||||||||
Interest expense | (489,000) | (616,000) | |||||||||||||||
Interest expense-financing fees | (228,000) | (192,000) | |||||||||||||||
Depreciation and amortization | 3,717,000 | 4,240,000 | |||||||||||||||
Segment income (loss) before income taxes | 480,000 | (2,575,000) | |||||||||||||||
Total income tax expense | 543,000 | 417,000 | |||||||||||||||
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest | (63,000) | (2,992,000) | |||||||||||||||
Segment assets | [1] | 83,065,000 | 88,251,000 | ||||||||||||||
Expenditures for segment assets | 623,000 | 464,000 | |||||||||||||||
Total debt | $ 9,988,000 | $ 11,372,000 | |||||||||||||||
|